Systemic immune-inflammation index and other inflammatory parameters in patients receiving biological or targeted synthetic DMARDs for inflammatory rheumatic disease

Gezer H. H., Pehlivan O.

MARMARA MEDICAL JOURNAL, cilt.35, sa.3, ss.316-322, 2022 (ESCI) identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 35 Sayı: 3
  • Basım Tarihi: 2022
  • Doi Numarası: 10.5472/marumj.1186732
  • Dergi Adı: MARMARA MEDICAL JOURNAL
  • Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), Scopus, Academic Search Premier, CINAHL, EMBASE, TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.316-322
  • Anahtar Kelimeler: Inflammation, Systemic immune inflammation index, Biological treatment, TO-LYMPHOCYTE RATIO, MEAN PLATELET VOLUME, NEUTROPHIL, PSORIASIS, MARKERS
  • Marmara Üniversitesi Adresli: Hayır

Özet

Objective: To investigate the short - and long-term dynamics in inflammation markers [systemic immune-inflammation index (SII), neutrophil/lymphocyte ratio (NLR), platelet/lymphocyte ratio (PLR), and lymphocyte/ monocyte ratio (LMR)] before and after biological disease-modifying antirheumatic drugs (bDMARD) or targeted synthetic DMARD (tsDMARD) treatment.